Inprother research published in Oncotarget

We are very happy to announce that a new scientic article by the Inprother-team has been accepted in the Oncotarget journal.

The article: “Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice by Lasse Neukirch, Tea Kirkegaard Nielsen, Henriette Laursen, Joana Daradoumis, Christian Thirion and Peter Johannes Holst

For more info: Please visit

Related news

SIRION Biotech Licenses Adenovirus Technology to Danish Startup, InProTher for its Novel Immunotherapy Design Targeting Endogenous Retrovirus (ERV)